Mabion SA
WSE:MAB

Watchlist Manager

Mabion SA

WSE:MAB

Watchlist

Dividends

Discount Rate

Price: 8.5 PLN -0.7% Market Closed

Market Cap: 137.4m PLN

Have any thoughts about
Mabion SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 8.5 PLN

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MAB Alert

Mabion SA

8.5

-0.06 (-0.7%)

52 Week Range	8.5 20.56
Price Target

We'll email you a reminder when the closing price reaches PLN.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Mabion SA

What unique competitive advantages
does Mabion SA hold over its rivals?

What risks and challenges
does Mabion SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Mabion SA.

What unique competitive advantages
does Mabion SA hold over its rivals?

What risks and challenges
does Mabion SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Mabion SA.

Provide P/S
for Mabion SA.

Provide P/E
for Mabion SA.

Provide P/OCF
for Mabion SA.

Provide P/FCFE
for Mabion SA.

Provide P/B
for Mabion SA.

Provide EV/S
for Mabion SA.

Provide EV/GP
for Mabion SA.

Provide EV/EBITDA
for Mabion SA.

Provide EV/EBIT
for Mabion SA.

Provide EV/OCF
for Mabion SA.

Provide EV/FCFF
for Mabion SA.

Provide EV/IC
for Mabion SA.

Show me price targets
for Mabion SA made by professional analysts.

What are the Revenue projections
for Mabion SA?

How accurate were the past Revenue estimates
for Mabion SA?

What are the Net Income projections
for Mabion SA?

How accurate were the past Net Income estimates
for Mabion SA?

What are the EPS projections
for Mabion SA?

How accurate were the past EPS estimates
for Mabion SA?

What are the EBIT projections
for Mabion SA?

How accurate were the past EBIT estimates
for Mabion SA?

Compare the revenue forecasts
for Mabion SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Mabion SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Mabion SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Mabion SA compared to its peers.

Compare the P/E ratios
of Mabion SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Mabion SA with its peers.

Analyze the financial leverage
of Mabion SA compared to its main competitors.

Show all profitability ratios
for Mabion SA.

Provide ROE
for Mabion SA.

Provide ROA
for Mabion SA.

Provide ROIC
for Mabion SA.

Provide ROCE
for Mabion SA.

Provide Gross Margin
for Mabion SA.

Provide Operating Margin
for Mabion SA.

Provide Net Margin
for Mabion SA.

Provide FCF Margin
for Mabion SA.

Show all solvency ratios
for Mabion SA.

Provide D/E Ratio
for Mabion SA.

Provide D/A Ratio
for Mabion SA.

Provide Interest Coverage Ratio
for Mabion SA.

Provide Altman Z-Score Ratio
for Mabion SA.

Provide Quick Ratio
for Mabion SA.

Provide Current Ratio
for Mabion SA.

Provide Cash Ratio
for Mabion SA.

What is the historical Revenue growth
over the last 5 years for Mabion SA?

What is the historical Net Income growth
over the last 5 years for Mabion SA?

What is the current Free Cash Flow
of Mabion SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Mabion SA.

EV/EBITDA
Enterprise Value to EBITDA

2.4

Current

3.9

Median

4.2

Industry

Lower than median

Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

2.4

Enterprise Value

92.3m PLN

EBITDA

39m PLN

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
PL	M	Mabion SA WSE:MAB	137.4m PLN	2.4
FR		Pharnext SCA OTC:PNEXF	6T USD	-219 476
US		Abbvie Inc NYSE:ABBV	310.2B USD	15.2
US		Amgen Inc NASDAQ:AMGN	142B USD	16.1
US		Gilead Sciences Inc NASDAQ:GILD	115B USD	10.1
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	101.6B USD	20.8
US	E	Epizyme Inc F:EPE	94.1B EUR	-514.8
AU		CSL Ltd ASX:CSL	134.4B AUD	19.7
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	78.5B USD	15.3
US	S	Seagen Inc F:SGT	39.3B EUR	-58.8
NL		argenx SE XBRU:ARGX	36B EUR	-109.5

				EBITDA Growth	EV/EBITDA to Growth
PL	M	Mabion SA WSE:MAB	Average EV/EBITDA: 14.2 2.4	N/A	N/A
FR		Pharnext SCA OTC:PNEXF	Negative Multiple: -219 476	N/A	N/A
US		Abbvie Inc NYSE:ABBV	15.2	29%	0.5
US		Amgen Inc NASDAQ:AMGN	16.1	62%	0.3
US		Gilead Sciences Inc NASDAQ:GILD	10.1	16%	0.6
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	20.8	43%	0.5
US	E	Epizyme Inc F:EPE	Negative Multiple: -514.8	N/A	N/A
AU		CSL Ltd ASX:CSL	19.7	42%	0.5
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	15.3	35%	0.4
US	S	Seagen Inc F:SGT	Negative Multiple: -58.8	N/A	N/A
NL		argenx SE XBRU:ARGX	Negative Multiple: -109.5	N/A	N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

5.2

2-Years Forward

EV/EBITDA

-8

3-Years Forward

EV/EBITDA

-6.3

	Franklin Covey Co NYSE:FC	36.225 USD -0.51%
	Mohawk Industries Inc NYSE:MHK	118.92 USD -0.2%
	Ardmore Shipping Corp NYSE:ASC	11.71 USD 3.54%
	ASGN Inc NYSE:ASGN	83.28 USD -0.7%
	Skyworks Solutions Inc NASDAQ:SWKS	89.34 USD 0.66%
	Weatherford International PLC NASDAQ:WFRD	68.08 USD 1.46%

	Johnson & Johnson NYSE:JNJ	143.6901 USD -0.54%
	Bank of America Corp NYSE:BAC	43.51 USD -1.49%
	Mastercard Inc NYSE:MA	523.6 USD -0.84%
	Salesforce Inc NYSE:CRM	339.73 USD -1.14%
	Abbvie Inc NYSE:ABBV	175.573218 USD 0%
	Home Depot Inc NYSE:HD	389.5601 USD -0.77%

	Arista Networks Inc NYSE:ANET	113.04 USD 0.2%
	Visa Inc NYSE:V	314.68 USD -0.95%
	Texas Pacific Land Corp NYSE:TPL	1 117.34 USD -1.39%
	KLA Corp NASDAQ:KLAC	637.52 USD 1.29%
	Manhattan Associates Inc NASDAQ:MANH	276.005 USD -1.52%
	Pinduoduo Inc NASDAQ:PDD	99.385 USD -0.13%

	Salesforce Inc NYSE:CRM	339.73 USD -1.14%
	Accenture PLC NYSE:ACN	355.75 USD -2.9%
	ServiceNow Inc NYSE:NOW	1 083.465 USD -0.71%
	EOG Resources Inc NYSE:EOG	119.07 USD 0.03%
	Copart Inc NASDAQ:CPRT	58.04 USD -0.31%
	Applied Materials Inc NASDAQ:AMAT	165.56 USD 1.2%

Mabion SA
WSE:MAB

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Mabion SA WSE:MAB

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

Mabion SA
WSE:MAB

EV/EBITDA
Enterprise Value to EBITDA